SlideShare a Scribd company logo
Contact Us : +1-416-915-4458
We Empower, You Comply!
Webiar Description:
Areas Covered in the Session :
Who Will Benefit:
Speaker Profile:
public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author. Dr. Lim leads
and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals
being conducted at the Regulatory Doctor.
This webinar is intended to demonstrate 510(k) contents and format including 510(k) processesin accordance with FDA’s
eCopy and RTA policy, helping you streamline your 510(k) preparation, submission and successful clearance for IVDs,
saving days, weeks or months of your time and efforts.
Although it is believed there may be various factors contributing to those nine (9) 510(k) clearances taking longer than 90
days, it is imperative more than ever from our industry perspectives that the medical device manufacturers understand
recent changes (hurdles and new requirements) and be able to prepare a 510(k) in a sufficiently adequate way to
expedite the review process, leading successful clearances without delays.
In this webinar, speaker will discuss what and how to do with your 510(k) preparation and submission. In particular, the
speaker will share what he has learned from his own experience and also based on his analysis of the above-mentioned
nine (9) IVD 510(k)s cleared in August, 2013.
To register for this webinar please visit our website www.compliancetrainings.com
510(k) for IVDs
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor
(www.RegulatoryDoctor.com). Dr. Lim frequently presents global regulatory and quality compliance
topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use
compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for
drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in
483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA)
through public comments and also served as a panel member during the FDA’s transparency
Tuesday, October 15, 2013
Duration : 60 Minutes
10:00 AM PDT | 01:00 PM EDT
Speaker | Dr. David Lim
> Statute(s) and regulations
> Regulatory requirements for 510(k)s
> Device classification and predicates
> When 510(k)s are required
> Demonstrating substantial equivalence
> Recent 510(k) changes and requirements including e-Copy and RTA policy
> Regulatory requirements for IVDs
> Standards and guidance applicable to IVDs
> How to address and present performance data and/or clinical data in a succinct, comprehensive manner.
> How to respond to FDA’s request of additional information.
> How to resolve different opinions between the submitter and FDA reviewer(s)
To register for this webinar please visit our website www.compliancetrainings.com
> RA
> R&D and CROs
> QA/QC/QS
> Consultants
> Contractors/subcontractors
> Senior management
> Anyone interested in 510(k) matters

More Related Content

Similar to 510k for IVDs

Us fda 510
Us fda 510Us fda 510
Webinar or Online Training on A comprehensive overview of 510(k) submission
Webinar or Online Training on A comprehensive overview of 510(k) submissionWebinar or Online Training on A comprehensive overview of 510(k) submission
Webinar or Online Training on A comprehensive overview of 510(k) submission
Complianz World
 
Webinar on medical device changes and the 510(k)
Webinar on medical device changes and the 510(k)Webinar on medical device changes and the 510(k)
Webinar on medical device changes and the 510(k)
Compliance Trainings
 
FDA De Novo & Medical Devices
FDA De Novo & Medical DevicesFDA De Novo & Medical Devices
FDA De Novo & Medical Devices
shane99
 
How fda trains its investigators to review capa
How fda trains its investigators to review capaHow fda trains its investigators to review capa
How fda trains its investigators to review capa
OnlineCompliance Panel
 
medical device changes and the 510(k)
medical device changes and the 510(k)medical device changes and the 510(k)
medical device changes and the 510(k)
Compliance Trainings
 
Ce marking mdd, aimdd and ivdd
Ce marking mdd, aimdd and ivddCe marking mdd, aimdd and ivdd
Ce marking mdd, aimdd and ivdd
OnlineCompliance Panel
 
Best practices for global regulatory intelligence do's & don'ts
Best practices for global regulatory intelligence do's & don'tsBest practices for global regulatory intelligence do's & don'ts
Best practices for global regulatory intelligence do's & don'ts
OnlineCompliance Panel
 
Premarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptxPremarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptx
SusmithaTella2
 
FDA’s 510(k) Pilot Programs
FDA’s 510(k) Pilot ProgramsFDA’s 510(k) Pilot Programs
FDA’s 510(k) Pilot Programs
EMMAIntl
 
Agile in a highly regulated organization 2014
Agile in a highly regulated organization 2014Agile in a highly regulated organization 2014
Agile in a highly regulated organization 2014
Tami Flowers
 
Fda at-my-facility-cape-town
Fda at-my-facility-cape-townFda at-my-facility-cape-town
Fda at-my-facility-cape-town
GlobalCompliancePanel
 
medical regulation.pdf
medical regulation.pdfmedical regulation.pdf
medical regulation.pdf
ssuser0e9b33
 
OSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
OSMA: Orthopedic Industry's Top Regulatory Challenges and OpportunitiesOSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
OSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
April Bright
 
The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011
The MarkeTech Group
 
Preparing for fda
Preparing for fdaPreparing for fda
Preparing for fda
supportc2go
 
Implementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated EnvironmentImplementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated Environment
TechWell
 
Overview of FDA Issues for Cardiovascular Device Makers
Overview of FDA Issues for Cardiovascular Device MakersOverview of FDA Issues for Cardiovascular Device Makers
Overview of FDA Issues for Cardiovascular Device Makers
Michael Swit
 
Darqa conference may 26 - 2016
Darqa   conference may 26 - 2016Darqa   conference may 26 - 2016
Darqa conference may 26 - 2016
QualiSense
 
Company_Brochure_for_Audit
Company_Brochure_for_AuditCompany_Brochure_for_Audit
Company_Brochure_for_Audit
Divya Ganapathy
 

Similar to 510k for IVDs (20)

Us fda 510
Us fda 510Us fda 510
Us fda 510
 
Webinar or Online Training on A comprehensive overview of 510(k) submission
Webinar or Online Training on A comprehensive overview of 510(k) submissionWebinar or Online Training on A comprehensive overview of 510(k) submission
Webinar or Online Training on A comprehensive overview of 510(k) submission
 
Webinar on medical device changes and the 510(k)
Webinar on medical device changes and the 510(k)Webinar on medical device changes and the 510(k)
Webinar on medical device changes and the 510(k)
 
FDA De Novo & Medical Devices
FDA De Novo & Medical DevicesFDA De Novo & Medical Devices
FDA De Novo & Medical Devices
 
How fda trains its investigators to review capa
How fda trains its investigators to review capaHow fda trains its investigators to review capa
How fda trains its investigators to review capa
 
medical device changes and the 510(k)
medical device changes and the 510(k)medical device changes and the 510(k)
medical device changes and the 510(k)
 
Ce marking mdd, aimdd and ivdd
Ce marking mdd, aimdd and ivddCe marking mdd, aimdd and ivdd
Ce marking mdd, aimdd and ivdd
 
Best practices for global regulatory intelligence do's & don'ts
Best practices for global regulatory intelligence do's & don'tsBest practices for global regulatory intelligence do's & don'ts
Best practices for global regulatory intelligence do's & don'ts
 
Premarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptxPremarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptx
 
FDA’s 510(k) Pilot Programs
FDA’s 510(k) Pilot ProgramsFDA’s 510(k) Pilot Programs
FDA’s 510(k) Pilot Programs
 
Agile in a highly regulated organization 2014
Agile in a highly regulated organization 2014Agile in a highly regulated organization 2014
Agile in a highly regulated organization 2014
 
Fda at-my-facility-cape-town
Fda at-my-facility-cape-townFda at-my-facility-cape-town
Fda at-my-facility-cape-town
 
medical regulation.pdf
medical regulation.pdfmedical regulation.pdf
medical regulation.pdf
 
OSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
OSMA: Orthopedic Industry's Top Regulatory Challenges and OpportunitiesOSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
OSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
 
The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011
 
Preparing for fda
Preparing for fdaPreparing for fda
Preparing for fda
 
Implementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated EnvironmentImplementing Agile in an FDA Regulated Environment
Implementing Agile in an FDA Regulated Environment
 
Overview of FDA Issues for Cardiovascular Device Makers
Overview of FDA Issues for Cardiovascular Device MakersOverview of FDA Issues for Cardiovascular Device Makers
Overview of FDA Issues for Cardiovascular Device Makers
 
Darqa conference may 26 - 2016
Darqa   conference may 26 - 2016Darqa   conference may 26 - 2016
Darqa conference may 26 - 2016
 
Company_Brochure_for_Audit
Company_Brochure_for_AuditCompany_Brochure_for_Audit
Company_Brochure_for_Audit
 

More from Anita Anzo

Project Management for Computer Systems Validation
Project Management for Computer Systems ValidationProject Management for Computer Systems Validation
Project Management for Computer Systems Validation
Anita Anzo
 
Cleaning Validations Using Extraction Techniques
Cleaning Validations Using Extraction TechniquesCleaning Validations Using Extraction Techniques
Cleaning Validations Using Extraction Techniques
Anita Anzo
 
21 CFR 11 Compliance for Excel Spreadsheets
21 CFR 11 Compliance for Excel Spreadsheets21 CFR 11 Compliance for Excel Spreadsheets
21 CFR 11 Compliance for Excel Spreadsheets
Anita Anzo
 
Creating Design History Files (DHF), the Device Master Records (DMR) and the ...
Creating Design History Files (DHF), the Device Master Records (DMR) and the ...Creating Design History Files (DHF), the Device Master Records (DMR) and the ...
Creating Design History Files (DHF), the Device Master Records (DMR) and the ...
Anita Anzo
 
Acceptance Activities in FDA QSR
Acceptance Activities in FDA QSRAcceptance Activities in FDA QSR
Acceptance Activities in FDA QSR
Anita Anzo
 
Marketing FDA Regulated Products Through Social Media
Marketing FDA Regulated Products Through Social MediaMarketing FDA Regulated Products Through Social Media
Marketing FDA Regulated Products Through Social Media
Anita Anzo
 
21 CFR Part 820 - Quality System Regulation - Applying Principles of Lean Doc...
21 CFR Part 820 - Quality System Regulation - Applying Principles of Lean Doc...21 CFR Part 820 - Quality System Regulation - Applying Principles of Lean Doc...
21 CFR Part 820 - Quality System Regulation - Applying Principles of Lean Doc...
Anita Anzo
 
How to manage virtual employees and achieve real results… any time… any place
How to manage virtual employees and achieve real results… any time… any placeHow to manage virtual employees and achieve real results… any time… any place
How to manage virtual employees and achieve real results… any time… any place
Anita Anzo
 
How to Manage a Product Medical Device Recall Efficiently and Effectively
How to Manage a Product Medical Device Recall Efficiently and EffectivelyHow to Manage a Product Medical Device Recall Efficiently and Effectively
How to Manage a Product Medical Device Recall Efficiently and Effectively
Anita Anzo
 
Construct and manage the technical file and design dossier
Construct and manage the technical file and design dossierConstruct and manage the technical file and design dossier
Construct and manage the technical file and design dossier
Anita Anzo
 
Creating Value: Employee Engagement at Work
Creating Value: Employee Engagement at WorkCreating Value: Employee Engagement at Work
Creating Value: Employee Engagement at Work
Anita Anzo
 
The Hitchhiker’s guide to 483s and warning letters
The Hitchhiker’s guide to 483s and warning lettersThe Hitchhiker’s guide to 483s and warning letters
The Hitchhiker’s guide to 483s and warning letters
Anita Anzo
 

More from Anita Anzo (12)

Project Management for Computer Systems Validation
Project Management for Computer Systems ValidationProject Management for Computer Systems Validation
Project Management for Computer Systems Validation
 
Cleaning Validations Using Extraction Techniques
Cleaning Validations Using Extraction TechniquesCleaning Validations Using Extraction Techniques
Cleaning Validations Using Extraction Techniques
 
21 CFR 11 Compliance for Excel Spreadsheets
21 CFR 11 Compliance for Excel Spreadsheets21 CFR 11 Compliance for Excel Spreadsheets
21 CFR 11 Compliance for Excel Spreadsheets
 
Creating Design History Files (DHF), the Device Master Records (DMR) and the ...
Creating Design History Files (DHF), the Device Master Records (DMR) and the ...Creating Design History Files (DHF), the Device Master Records (DMR) and the ...
Creating Design History Files (DHF), the Device Master Records (DMR) and the ...
 
Acceptance Activities in FDA QSR
Acceptance Activities in FDA QSRAcceptance Activities in FDA QSR
Acceptance Activities in FDA QSR
 
Marketing FDA Regulated Products Through Social Media
Marketing FDA Regulated Products Through Social MediaMarketing FDA Regulated Products Through Social Media
Marketing FDA Regulated Products Through Social Media
 
21 CFR Part 820 - Quality System Regulation - Applying Principles of Lean Doc...
21 CFR Part 820 - Quality System Regulation - Applying Principles of Lean Doc...21 CFR Part 820 - Quality System Regulation - Applying Principles of Lean Doc...
21 CFR Part 820 - Quality System Regulation - Applying Principles of Lean Doc...
 
How to manage virtual employees and achieve real results… any time… any place
How to manage virtual employees and achieve real results… any time… any placeHow to manage virtual employees and achieve real results… any time… any place
How to manage virtual employees and achieve real results… any time… any place
 
How to Manage a Product Medical Device Recall Efficiently and Effectively
How to Manage a Product Medical Device Recall Efficiently and EffectivelyHow to Manage a Product Medical Device Recall Efficiently and Effectively
How to Manage a Product Medical Device Recall Efficiently and Effectively
 
Construct and manage the technical file and design dossier
Construct and manage the technical file and design dossierConstruct and manage the technical file and design dossier
Construct and manage the technical file and design dossier
 
Creating Value: Employee Engagement at Work
Creating Value: Employee Engagement at WorkCreating Value: Employee Engagement at Work
Creating Value: Employee Engagement at Work
 
The Hitchhiker’s guide to 483s and warning letters
The Hitchhiker’s guide to 483s and warning lettersThe Hitchhiker’s guide to 483s and warning letters
The Hitchhiker’s guide to 483s and warning letters
 

510k for IVDs

  • 1. Contact Us : +1-416-915-4458 We Empower, You Comply! Webiar Description: Areas Covered in the Session : Who Will Benefit: Speaker Profile: public meeting in 2009. Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author. Dr. Lim leads and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. This webinar is intended to demonstrate 510(k) contents and format including 510(k) processesin accordance with FDA’s eCopy and RTA policy, helping you streamline your 510(k) preparation, submission and successful clearance for IVDs, saving days, weeks or months of your time and efforts. Although it is believed there may be various factors contributing to those nine (9) 510(k) clearances taking longer than 90 days, it is imperative more than ever from our industry perspectives that the medical device manufacturers understand recent changes (hurdles and new requirements) and be able to prepare a 510(k) in a sufficiently adequate way to expedite the review process, leading successful clearances without delays. In this webinar, speaker will discuss what and how to do with your 510(k) preparation and submission. In particular, the speaker will share what he has learned from his own experience and also based on his analysis of the above-mentioned nine (9) IVD 510(k)s cleared in August, 2013. To register for this webinar please visit our website www.compliancetrainings.com 510(k) for IVDs Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor (www.RegulatoryDoctor.com). Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency Tuesday, October 15, 2013 Duration : 60 Minutes 10:00 AM PDT | 01:00 PM EDT Speaker | Dr. David Lim > Statute(s) and regulations > Regulatory requirements for 510(k)s > Device classification and predicates > When 510(k)s are required > Demonstrating substantial equivalence > Recent 510(k) changes and requirements including e-Copy and RTA policy > Regulatory requirements for IVDs > Standards and guidance applicable to IVDs > How to address and present performance data and/or clinical data in a succinct, comprehensive manner. > How to respond to FDA’s request of additional information. > How to resolve different opinions between the submitter and FDA reviewer(s) To register for this webinar please visit our website www.compliancetrainings.com > RA > R&D and CROs > QA/QC/QS > Consultants > Contractors/subcontractors > Senior management > Anyone interested in 510(k) matters